UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ph− myeloproliferative neoplasms and the related risk factors for stroke occurrence: Results from a registry of patients treated with Anagrelide

Journal of thrombosis and thrombolysis, 2021, Vol.51 (1), p.112-119

2021

Volltextzugriff (PDF)

Fibrin Clot Architecture in Acute Ischemic Stroke Treated With Mechanical Thrombectomy With Stent-Retrievers　― Cohort Study

Circulation Journal, 2018/02/23, Vol.82(3), pp.866-873

2018

Volltextzugriff (PDF)

Antithrombin Deficiency: Frequency in Patients with Thrombosis and Thrombophilic Families

Acta medica Lékarskí fakulty Univerzity Karlovy v Hradci Králove, 2023, Vol.66 (1), p.19-23

2023

Volltextzugriff (PDF)

Whole Blood Samples for Faster Real-Time PCR Analysis of Thrombophilic Mutations in SARS-CoV-2 Virus Positive Patients

Physiological research, 2022-05, Vol.71 (3), p.439-445

2022

Volltextzugriff (PDF)

Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)

Annals of hematology, 2023-11, Vol.102 (11), p.3261-3270

2023

Volltextzugriff (PDF)

Identifying risk factors and optimizing standard of care for patients with acquired haemophilia A: Results from a Czech patient cohort

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-07, Vol.26 (4), p.643-651

2020

Volltextzugriff (PDF)

Thrombosis in thrombocythemic Ph- myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide

European journal of haematology, 2016-01, Vol.96 (1), p.98-106

2016

Volltextzugriff (PDF)

Treatment of polycythemia vera

Vnitřní lékar̆stvĭ, 2018-10, Vol.64 (10), p.955-960

Dulíček, Petr

2018

Volltextzugriff (PDF)

Diagnosis, etiology and management of the Budd-Chiari Syndrome: a bloodcoagulation and hepatological study on the course of the disease treated with TIPS

International angiology, 2016-02, Vol.35 (1), p.90

2016

Volltextzugriff (PDF)

Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b

Leukemia, 2022-05, Vol.36 (5), p.1408-1411

2022

Volltextzugriff (PDF)

The Purple Toe Syndrome in Female With Factor V Leiden Mutation Successfully Treated With Enoxaparin

Clinical and applied thrombosis/hemostasis, 2013-01, Vol.19 (1), p.100-102

2013

Volltextzugriff (PDF)

Rivaroxaban - 4 year experience in the treatment of deep vein thrombosis

Intervenční a akutní kardiologie, 2016-12, Vol.15 (4), p.183-186

Dulíček, Petr

2016

Volltextzugriff (PDF)

Antiphospholipid syndrome and thrombosis

Klinická farmakologie a farmacie, 2016-05, Vol.30 (1), p.42-43

Dulíček, Petr

2016

Volltextzugriff (PDF)

Case 1-2013: fatal manifestation of myeloproliferative disease

Acta medica (Hradec Kralove), 2013, Vol.56 (1), p.33-35

2013

Volltextzugriff (PDF)

Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases

Journal of thrombosis and thrombolysis, 2017-04, Vol.43 (3), p.306-317

2017

Volltextzugriff (PDF)

Analysis of Risk Factors of Stroke and Venous Thromboembolism in Females With Oral Contraceptives Use

Clinical and applied thrombosis/hemostasis, 2018-07, Vol.24 (5), p.797-802

2018

Volltextzugriff (PDF)

Direct anticoagulants and general practitioner

Medicína pro praxi, 2022-02, Vol.19 (1), p.58-61

2022

Volltextzugriff (PDF)

Investigation of congenital thrombophilic conditions: when, in whom, focusing on what or not at all?

Vnitřní lékar̆stvĭ, 2018-07, Vol.64 (5), p.559-563

2018

Volltextzugriff (PDF)

P1034: FROM SNAPSHOT TO CONTINUUM: CUMULATIVE TIME IN RESPONSE AS AN EMERGING PROXY FOR THROMBOTIC RISK IN POLYCYTHEMIA VERA

HemaSphere, 2023-08, Vol.7 (S3), p.e216416f-n/a

2023

Volltextzugriff (PDF)

Venous Thromboembolism in Young Female While on Oral Contraceptives: High Frequency of Inherited Thrombophilia and Analysis of Thrombotic Events in 400 Czech Women

Clinical and applied thrombosis/hemostasis, 2009-10, Vol.15 (5), p.567-573

2009

Volltextzugriff (PDF)

Ropeginterferon Alfa‐2b: Efficacy and Safety in Different Age Groups

HemaSphere, 2020-12, Vol.4 (6), p.e485-n/a

2020

Volltextzugriff (PDF)

Splanchnic vein thrombosis: aetiology, therapy, and results – a retrospective analysis

Transfuze a hematologie dnes, 2024-06, Vol.30 (2)

2024

Volltextzugriff (PDF)

Analysis of Risk Factors: The Rationale of the Guidelines of the Czech Hematological Society for Diagnosis and Treatment of Chronic Myeloproliferative Disorders with Thrombocythemia

Seminars in thrombosis and hemostasis, 2006-04, Vol.32 (3), p.231-245

2006

Volltextzugriff (PDF)

Prehepatic portal hypertension

Gastroenterologie a hepatologie, 2016-10, Vol.70 (5), p.432-437

2016

Volltextzugriff (PDF)

Risk of Thrombosis in Patients Homozygous and Heterozygous for Factor V Leiden in the East Bohemian Region

Clinical and applied thrombosis/hemostasis, 2000-04, Vol.6 (2), p.87-89

2000

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(54)

Sprache

Englisch
(53)
Tschechisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ph− myeloproliferative neoplasms and the related risk factors for stroke occurrence: Results from a registry of patients treated with Anagrelide

Fibrin Clot Architecture in Acute Ischemic Stroke Treated With Mechanical Thrombectomy With Stent-Retrievers　― Cohort Study

Antithrombin Deficiency: Frequency in Patients with Thrombosis and Thrombophilic Families

Whole Blood Samples for Faster Real-Time PCR Analysis of Thrombophilic Mutations in SARS-CoV-2 Virus Positive Patients

Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)

Identifying risk factors and optimizing standard of care for patients with acquired haemophilia A: Results from a Czech patient cohort

Thrombosis in thrombocythemic Ph- myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide

Treatment of polycythemia vera

Diagnosis, etiology and management of the Budd-Chiari Syndrome: a bloodcoagulation and hepatological study on the course of the disease treated with TIPS

Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b

The Purple Toe Syndrome in Female With Factor V Leiden Mutation Successfully Treated With Enoxaparin

Rivaroxaban - 4 year experience in the treatment of deep vein thrombosis

Antiphospholipid syndrome and thrombosis

Case 1-2013: fatal manifestation of myeloproliferative disease

Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases

Analysis of Risk Factors of Stroke and Venous Thromboembolism in Females With Oral Contraceptives Use

Direct anticoagulants and general practitioner

Investigation of congenital thrombophilic conditions: when, in whom, focusing on what or not at all?

P1034: FROM SNAPSHOT TO CONTINUUM: CUMULATIVE TIME IN RESPONSE AS AN EMERGING PROXY FOR THROMBOTIC RISK IN POLYCYTHEMIA VERA

Venous Thromboembolism in Young Female While on Oral Contraceptives: High Frequency of Inherited Thrombophilia and Analysis of Thrombotic Events in 400 Czech Women

Ropeginterferon Alfa‐2b: Efficacy and Safety in Different Age Groups

Splanchnic vein thrombosis: aetiology, therapy, and results – a retrospective analysis

Analysis of Risk Factors: The Rationale of the Guidelines of the Czech Hematological Society for Diagnosis and Treatment of Chronic Myeloproliferative Disorders with Thrombocythemia

Prehepatic portal hypertension

Risk of Thrombosis in Patients Homozygous and Heterozygous for Factor V Leiden in the East Bohemian Region

Suchergebnisse filtern